Skip to Content

135 (Nimodipine 30 mg)

Pill with imprint 135 is Yellow, Capsule-shape and has been identified as Nimodipine 30 mg. It is supplied by Caraco Pharmaceutical Laboratories.

Nimodipine is used in the treatment of subarachnoid hemorrhage; ischemic stroke; migraine prevention and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nimodipine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 135

Nimodipine 30 mg 135

Nimodipine

Imprint:
135
Strength:
30 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcium channel blocking agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Caraco Pharmaceutical Laboratories
Inactive Ingredients:
glycerin
peppermint oil
water
polyethylene glycol
gelatin
D&C Yellow No. 10
titanium dioxide
ammonia
ferrosoferric oxide
butyl alcohol
isopropyl alcohol
shellac
alcohol
propylene glycol
medium-chain triglycerides
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide